(Q38375426)
Statements
1 reference
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer (English)
1 reference
Thomas Wehler
Christian Schumann
Nuria Viñolas Segarra
Nicolas J Dickgreber
Klaus Dalhoff
Martin Sebastian
Jesus Corral Jaime
Miriam Alonso
Scott M Hynes
Ji Lin
Karla Hurt
Aimee Bence Lin
6 March 2017
1 reference